Impact Biomedical
Impact Biomedical Inc. is an emerging human healthcare company and is a wholly owned subsidiary of DSS, Inc. The company is evaluating strategic options to accelerate value creation and has an existing collection of technology assets, distribution rights, and investments.
Strategy
Impact Biomedical Inc. is a unique provider of natural and plant-based technology and business partner in addressing unmet needs in human healthcare and wellness.
Licensing
Impact Biomedical develops valuable and unique patented technologies which could be licensed to pharmaceutical companies and venture capitalists in exchange for an agreed payment (fee or royalty). This interest will rise as the validating data becomes available.
Research Focus
- BioTech/ Med-Tech
(FDA/EMA Regulated) - Consumer Wellness/
Direct Market/ OTC - Emerging
Technologies
Our Technologies
Research & Licensing Focus
Medical Advancements & Treatments
- Oncology
- Neurology
- Inflammatory Disease
- Vaccines & Antivirals
- Antimicrobials
- Natural Treatments
- Therapeutic medical foods
- New classes of medicinal chemistry
Consumer Products & Technology
- Sugar Substitute
- Insect and Mosquito Repellent
- Vitamins
- Probiotics
- Immune Supplement
- OTC Medicine
- Polyphenols
- Advanced plastics